GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Wesana Health Holdings Inc (XCNQ:WESA.X) » Definitions » EV-to-EBITDA

Wesana Health Holdings (XCNQ:WESA.X) EV-to-EBITDA : -0.27 (As of May. 26, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Wesana Health Holdings EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Wesana Health Holdings's enterprise value is C$0.39 Mil. Wesana Health Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was C$-1.42 Mil. Therefore, Wesana Health Holdings's EV-to-EBITDA for today is -0.27.

The historical rank and industry rank for Wesana Health Holdings's EV-to-EBITDA or its related term are showing as below:

XCNQ:WESA.X' s EV-to-EBITDA Range Over the Past 10 Years
Min: -17.2   Med: -0.2   Max: 0.23
Current: -0.27

During the past 4 years, the highest EV-to-EBITDA of Wesana Health Holdings was 0.23. The lowest was -17.20. And the median was -0.20.

XCNQ:WESA.X's EV-to-EBITDA is ranked worse than
100% of 451 companies
in the Biotechnology industry
Industry Median: 9.67 vs XCNQ:WESA.X: -0.27

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-26), Wesana Health Holdings's stock price is C$0.02. Wesana Health Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.000. Therefore, Wesana Health Holdings's PE Ratio for today is N/A.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Wesana Health Holdings EV-to-EBITDA Historical Data

The historical data trend for Wesana Health Holdings's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wesana Health Holdings EV-to-EBITDA Chart

Wesana Health Holdings Annual Data
Trend Apr20 Apr21 Dec22 Dec23
EV-to-EBITDA
- - -0.10 -0.03

Wesana Health Holdings Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.15 -0.16 -0.10 0.06 -0.03

Competitive Comparison of Wesana Health Holdings's EV-to-EBITDA

For the Biotechnology subindustry, Wesana Health Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wesana Health Holdings's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Wesana Health Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Wesana Health Holdings's EV-to-EBITDA falls into.



Wesana Health Holdings EV-to-EBITDA Calculation

Wesana Health Holdings's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=0.386/-1.42
=-0.27

Wesana Health Holdings's current Enterprise Value is C$0.39 Mil.
Wesana Health Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.42 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wesana Health Holdings  (XCNQ:WESA.X) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Wesana Health Holdings's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.02/0.000
=N/A

Wesana Health Holdings's share price for today is C$0.02.
Wesana Health Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Wesana Health Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Wesana Health Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Wesana Health Holdings (XCNQ:WESA.X) Business Description

Traded in Other Exchanges
Address
745 Thurlow Street, Suite 2400, Vancouver, BC, CAN, V6E 0C5
Wesana Health Holdings Inc is an emerging life sciences company championing the development and delivery of psychedelic and naturally-sourced therapies to treat traumatic brain injury. The Company is developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological, and mental health ailments caused by trauma with the help of extensive clinical research and academic partnerships.

Wesana Health Holdings (XCNQ:WESA.X) Headlines

No Headlines